Pfizer’s New Pediatric Eczema Study: A Potential Game-Changer? TipRanks Source link
Pfizer’s New Study on Abrocitinib: A Potential Game-Changer for Pediatric Eczema TipRanks Source link
Discussing Allergy and Pediatric Atopic Dermatitis, with Lisa Swanson, MD HCPLive Source link
On April 29, 2024, The US Food and Drug Administration (FDA) has accepted a Supplemental New Drug Application for tapinarof cream, 1%, for the topical treatment of atopic dermatitis in adults and children aged ≥ 2 years, according to an announcement by the manufacturer, Dermavant Sciences. Tapinarof cream, 1% (VTAMA) is a steroid-free aryl hydrocarbon […]